Restoring Skin Pigmentation in Vitiligo With Advanced Treatments
EP. 1: Prevalence of Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Drs Brittany Craiglow and Nada Elbuluk review the precipitating factors that trigger vitiligo, as well as segmental vs nonsegmental vitiligo.
EP. 2: Assessment of Vitiligo Severity
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Ted Lain, MD, breaks down the use of the Vitiligo Area Scoring Index calculations to assess vitiligo severity.
EP. 3: Quality of Life for Vitiligo Patients
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Heather Woolery-Lloyd, MD, comments on the emotional impact of vitiligo on patients’ quality of life.
EP. 4: Treatment Goals in Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Expert dermatologists share approaches to treating patients with vitiligo, focusing on patient communication and the use of combination therapy.
EP. 5: Mechanism of Repigmentation in Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Ted Lain, MD, reviews the rates and patterns of repigmentation of the skin in vitiligo and how the timeline is different for each patient.
EP. 6: Measuring Vitiligo Treatment Response
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Brittany Craiglow, MD, discusses the lengthy nature of vitiligo treatment response and how to approach communicating with patients who want to see change quickly.
EP. 7: Use of Ruxolitinib for Treatment of Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Experts in dermatology review the mechanism of action and clinical trials of topical ruxolitinib for repigmenting the skin in vitiligo.
EP. 8: Impact of UV Light Exposure on Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Expert dermatologists comment on the impact of UV light exposure on areas of the skin with vitiligo and their recommendations for sunscreen use.
EP. 9: Adverse Events of Ruxolitinib in Vitiligo Trials
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Heather Woolery-Lloyd, MD, discusses the adverse event profile of topical ruxolitinib for treatment of vitiligo, highlighting the well-tolerated nature of the drug.
EP. 10: Treatment Approaches to Ruxolitinib in Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Experts in dermatology share their impressions of ruxolitinib and approaches to vitiligo treatment in clinical practice.
EP. 11: Treatment Response to Conventional vs Emerging Therapies in Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Nada Elbuluk, MD, and Ted Lain, MD, compare response to conventional treatment options vs emerging therapies, such as ruxolitinib, in the treatment of vitiligo.
EP. 12: Disease Burden for Patients With Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Expert dermatologists discuss the impact of vitiligo and vitiligo treatment on quality of life.
EP. 13: Managing Vitiligo Patient Expectations
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Heather Woolery-Lloyd, MD, and Nada Elbuluk, MD, share approaches to patient education and managing patient expectations when repigmenting the skin in vitiligo.
EP. 14: Promoting Access to New Therapies in Vitiligo
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Experts in dermatology comment on the need to promote access to emerging treatments in vitiligo.
EP. 15: Key Takeaways on Vitiligo Management
BySeemal R. Desai, MD,Heather Woolery-Lloyd, MD,Brittany G. Craiglow, MD,Nada Elbuluk, MD, MSc, FAAD,Ted Lain, MD Expert dermatologists share final thoughts on treatment of vitiligo and topical ruxolitinib.
